SERPINE1, PAI-1protein coding gene, methylation levels and epigenetic relationships with adiposity changes in obese subjects with metabolic syndrome features under dietary restriction

Journal of Clinical Biochemistry and Nutrition

Volumn 53, Issue 3, 2013, Pages 139-144

  Lopez Legarrea, Patricia ^a   Mansego, Maria Luisa ^a,b   Zulet, Marian Angeles ^a,b   Martinez, Jose Alfredo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Dna methylation; Energy restriction; Metabolic syndrome; PAI 1; SERPINE1 gene

Indexed keywords

CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE 1 PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DNA METHYLATION; DOUBLE BLIND PROCEDURE; EPIGENETICS; FAT MASS; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; METABOLIC SYNDROME X; NUTRITION; OBESITY; PROTEIN METHYLATION;

EID: 84890232691     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.13-54     Document Type: Article

References (41)

1. Declerck PJ, Gils A. Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin. Semin Thromb Hemost 2013; 39: 356-364.
2. Huang J, Sabater-Lleal M, Asselbergs FW, et al. Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood 2012; 120: 4873-1881.
3. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000; 342: 1792-1801.
4. Festa A, Williams K, Tracy RP, Wagenknecht LE, Haffner SM. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes. Circulation 2006; 113: 1753-1759.
5. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
6. Alessi MC, Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol 2006; 26: 2200-2207.
7. Martinez JA, Parra MD, Santos JL, Moreno-Aliaga MJ, Marti A, Martinez-Gonzalez MA. Genotype-dependent response to energy-restricted diets in obese subjects: towards personalized nutrition. Asia Pac J Clin Nutr 2008; 17: 119-122.
8. Campión J, Milagro F, Martínez JA. Epigenetics and obesity. Prog Mol Biol Transl Sci 2010; 94: 291-347.
9. Abete I, Astrup A, Martinez JA, Thorsdottir I, Zulet MA. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev 2010; 68: 214-231.
10. Cordero P, Campion J, Milagro FI, et al. Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J Physiol Biochem 2011; 67: 463-470.
11. Campión J, Milagro FI, Martinez JA. Individuality and epigenetics in obesity. Obes Rev 2009; 10: 383-392.
12. Zulet MA, Bondia-Pons I, Abete I, et al. The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control. Nutr Hosp 2011; 26: 16-26.
13. Lopez-Legarrea P, de la Iglesia R, Abete I, et al. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial. Nutr Metab (Land) 2013; 10: 22.
14. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
15. Morimoto A, Tatsumi Y, Deura K, et al. Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study. Diabetologia 2013; 56: 1671-1679.
16. Lee MJ, Wu Y, Fried SK. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med 2013; 34: 1-11.
17. Hermsdorff HH, Barbosa KB, Volp AC, et al. Gender-specific relationships between plasma oxidized low-density lipoprotein cholesterol, total anti-oxidant capacity, and central adiposity indicators. Eur J Prev Cardiol 2012; in press.
18. Jahagirdar R, Hemchand KP, Chiplonkar SA, Khadilkar VV, Khadilkar AV. Relationship between body mass index, fat distribution and cardiometabolic risk factors in Indian children and adolescents. Pediatr Obes 2012; 7: E37-E41.
19. Zhang FF, Santella RM, Wolff M, Kappil MA, Markowitz SB, Morabia A. White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population. Epigenetics 2012; 7: 606-614.
20. Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006; 5: 37-50.
21. Xu X, Su S, Barnes VA, et al. A genome-wide methylation study on obesity: differential variability and differential methylation. Epigenetics 2013; 8: 522-533.
22. Moleres A, Campión J, Milagro FI, et al. Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study. Faseb J 2013; 27: 2504-2512.
23. Wang X, Zhu H, Snieder H, et al. Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Med 2010; 8: 87.
24. Zhang FF, Cardarelli R, Carroll J, et al. Physical activity and global genomic DNA methylation in a cancer-free population. Epigenetics 2011; 6: 293-299.
25. Zhu ZZ, Hou L, Bollati V, et al. Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol 2012; 41: 126-139.
26. Bondia-Pons I, Ryan L, Martinez JA. Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem 2012; 68: 701-711.
27. Richard C, Couture P, Desroches S, Lamarche B. Effect of the mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndrome. Obesity (Silver Spring) 2013; 21: 51-57.
28. Moreira PF, Dalboni MA, Cendoroglo M, Santos GM, Cendoroglo MS. Postprandial interleukin-6 response in elderly with abdominal obesity and metabolic syndrome. J Nutr Health Aging 2013; 17: 206-210.
29. Hermsdorff HH, Puchau B, Zulet MA, Martinez JA. Association of body fat distribution with proinflammatory gene expression in peripheral blood mononuclear cells from young adult subjects. Omics 2010; 14: 297-307.
30. Bhupathiraju SN, Lichtenstein AH, Dawson-Hughes B, Tucker KL. Adherence index based on the AHA 2006 diet and lifestyle recommendations is associated with select cardiovascular disease risk factors in older Puerto Ricans. J Nutr 2011; 141: 460-469.
31. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke 2000; 31: 2751-2766.
32. Jago R, Mendoza JA, Chen T, Baranowski T. Longitudinal associations between BMI, waist circumference, and cardiometabolic risk in US youth: Monitoring implications. Obesity (Silver Spring) 2013; 21: E271-E279.
33. Hernández-Mijares A, Bañuls C, Gómez-Balaguer M, Bergoglio M, Victor VM, Rocha M. Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome. Eur J Clin Invest 2013; 43: 549-556.
34. Liu J, Li X, Yu N, et al. Genetic instability and CpG methylation in the 5′-flanking region of the PAI-1 gene in Chinese patients with gastric cancer. Genet Mol Res 2012; 11: 2899-2908.
35. Li M, Wu H, Wang T, et al. Co-methylated genes in different adipose depots of pig are associated with metabolic, inflammatory and immune processes. Int J Biol Sci 2012; 8: 831-837.
36. Wieser V, Moschen AR, Tilg H. Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp (Warsz) 2013; 61: 119-125.
37. Campión J, Milagro FI, Goyenechea E, Martínez JA. TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring) 2009; 17: 1293-1297.
38. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878-4884.
39. Burnett E, Christensen J, Tattersall P. A consensus DNA recognition motif for two KDWK transcription factors identifies flexible-length, CpG-methylation sensitive cognate binding sites in the majority of human promoters. J Mol Biol 2001; 314: 1029-1039.
40. Venugopal J, Hanashiro K, Nagamine Y. Regulation of PAI-1 gene expression during adipogenesis. J Cell Biochem 2007; 101: 369-380.
41. Gao S, Skeldal S, Krogdahl A, Sørensen JA, Andreasen PA. CpG methylation of the PAI-1 gene 5′-flanking region is inversely correlated with PAI-1 mRNA levels in human cell lines. Thromb Haemost 2005; 94: 651-660.